...
首页> 外文期刊>International Journal of Cardiology >A new kaolin-based hemostatic bandage use after coronary diagnostic and interventional procedures
【24h】

A new kaolin-based hemostatic bandage use after coronary diagnostic and interventional procedures

机译:一种新的基于高岭土的止血绷带在冠状动脉诊断和介入治疗后使用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Bleeding and vascular access site complications are an important cause of morbidity after percutaneous femoral procedures. Together with collagen-based and suture-based vascular closure devices, new hemostatic dressings have been developed to control heavy bleeding. Aim of study: To evaluate safety and efficacy results of the first clinical QuikClot Interventional Hemostatic Bandage use for femoral artery closure after diagnostic or interventional procedures. Methods: The first European safety study was performed at the Centro Cardiologico Monzino in Milan, Italy, on January 2010. Forty consecutive patients (75% male, mean age 68 ± 11 years) undergoing diagnostic angiography (62%) or PCI (38%) by femoral approach with a 6- (90%) or 7-Fr (10%) size introducer, received arterial sheath removal with the QuikClot Interventional gauze use. The mean ACT value at hemostasis time was 138 ± 24 s (range 95-186 s). Hemostasis was achieved in a mean time of 4.9 ± 0.5 min. Only one hemostasis failure occurred requiring prolonged mechanical compression. Neither major bleeding, re-bleeding nor hematoma occurred after early (4 h after procedure) ambulation. Conclusions: QuikClot Interventional Bandage obtained prompt hemostasis and allowed for an early ambulation without clinical complications.
机译:背景:经皮股骨手术后出血和血管通路部位并发症是发病的重要原因。结合基于胶原蛋白和基于缝合线的血管闭合装置,已开发出新的止血敷料来控制大量出血。研究目的:在诊断或介入程序后,评估首次临床QuikClot介入止血绷带用于股动脉闭合的安全性和疗效结果。方法:2010年1月在意大利米兰的Centro Cardiologico Monzino进行了首次欧洲安全性研究。连续40例接受诊断性血管造影(62%)或PCI(38%)的患者(男性75%,平均年龄68±11岁) ),使用尺寸为6-(90%)或7-Fr(10%)的导引器进行股骨入路,并使用QuikClot介入纱布将动脉鞘去除。止血时的平均ACT值为138±24 s(范围95-186 s)。在4.9±0.5分钟的平均时间内实现了止血。仅发生了一次止血失败,需要长时间的机械压缩。早期(手术后4小时)下床活动未发生大出血,再出血或血肿。结论:QuikClot介入绷带获得了快速止血,并允许早期走动而没有临床并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号